Highlights
IIA supported (ever)
About
Scent-based Cancer Detection Technology
SpotitEarly develops scent based multi-cancer early detection screening test, combining proprietary AI stack with bio-detectors, to detect cancer at its early stages and save people’s lives.
Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate cancers in one test. During training phase, the test showed higher sensitivity and better specificity in detecting early stages of cancer compared to any existing test on the market today.
Identity
| Name | SpotitEarly |
|---|---|
| Slug | spotitearly |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkOKj-ccJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District,Jerusalem District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv, Israel |
Web & social
| Website | https://www.spotitearly.com |
|---|---|
| https://www.linkedin.com/company/76644611 | |
| Twitter / X | https://twitter.com/spot_it_early |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
Artificial IntelligenceDeep Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business models
B2B
Tags
cancerdogsartificial-intelligencehealthcarecancer-diagnostics
Funding
| Total raised | $26.5M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}